Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Neoplasms × sapanisertib × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 2 Ovarian Neoplasms 2 Advanced Nonhematologic Malignancies 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Somatostatinoma 1 Sarcoma, Synovial 1 Sarcoma 1 Recurrent Lung Squamous Cell Carcinoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Non-hematologic Malignancy 1 Neurofibrosarcoma 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hematologic Neoplasms 1 Glioblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Dermatofibrosarcoma 1 Carcinoma, Transitional Cell 1

Interventions

Paclitaxel 6 Radiotherapy 2 Pemetrexed 2 Carboplatin 2 Brachytherapy 2 tucatinib 1 seribantumab 1 osimertinib 1 gedatolisib 1 fosaprepitant 1 fluciclovine F-18 1 cobimetinib 1 atezolizumab 1 alovudine 1 Trastuzumab 1 Therapeutics 1 TP protocol 1 Saline Solution 1 Radiation 1 Protons 1 Palliative Care 1 Nivolumab 1 Letrozole 1 Immunoglobulin G 1 Imatinib Mesylate 1 Ifosfamide 1 Gemcitabine 1 Fulvestrant 1 FANG vaccine 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡